Method for producing solifenacin or salts thereof
    65.
    发明申请
    Method for producing solifenacin or salts thereof 有权
    索非那新或其盐的制备方法

    公开(公告)号:US20070185329A1

    公开(公告)日:2007-08-09

    申请号:US11587826

    申请日:2005-04-25

    IPC分类号: C07D453/02

    摘要: There is provided a novel method for producing solifenacin or a salt thereof which is useful as a medicine, particularly a therapeutic agent and/or a preventive agent for a urinary organ system disease such as pollakiuria or urinary incontinence. Illustratively, there are provided (1) a method for producing solifenacin in which 2-(1H-imidazolylcarbonyl)-1-phenyltetrahydroisoquinoline is used as the starting material, (2) a method for producing solifenacin succinate in which (1RS)-phenyltetrahydroisoquinoline-carboxylic acid quinuclidinyl ester is used as the starting material, (3) a method for producing solifenacin in which a lower alkyl quinuclidinyl carbonate is used as the starting material and (4) a method for producing solifenacin in which phenyltetrahydroisoquinoline-carboxylic acid secondary lower alkyl or tertiary lower alkyl ester is used as the starting material and allowed to react with an alkali metal lower alkoxide.

    摘要翻译: 提供了一种可用作药物,特别是用于尿液器官系统疾病如尿频或尿失禁的治疗剂和/或预防剂的索利那芬或其盐的新方法。 (1)制备其中使用2-(1H-咪唑基羰基)-1-苯基四氢异喹啉作为起始原料的索非那新的方法,(2)一种制备其中(1RS) - 苯基四氢异喹啉-2-酮的苯达辛酸solifenacin的方法, 羧酸奎宁环酯用作原料,(3)制备其中使用低级烷基奎宁环基碳酸酯作为起始原料的索非那新的方法,(4)制备索非那新的方法,其中苯基四氢异喹啉羧酸二级低级烷基 或叔低级烷基酯作为原料,并与碱金属低级醇盐反应。

    SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
    66.
    发明申请
    SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION 失效
    磺酰胺衍生物,其制备及其治疗应用

    公开(公告)号:US20070185136A1

    公开(公告)日:2007-08-09

    申请号:US11670586

    申请日:2007-02-02

    摘要: Disclosed are compounds having the general formula (I) as defined herein, the preparation thereof, and the use thereof for the prophylaxis or treatment of any disease involving a dysfunction associated with the orexin 2 receptor such as obesity, appetite or taste disorders including cachexia, anorexia and bulimia, diabetes, metabolic syndromes, vomiting and nausea, depression and anxiety, addictions, mood and behaviour disorders, schizophrenia, sleep disorders, restless legs syndrome, memory learning disorders, sexual and psychosexual dysfunctions, pain, visceral or neuropathic pain, hyperalgesia, allodynia, digestive disorders, irritable bowel syndrome, neuronal degenerescence, ischaemic or haemorrhagic attacks, Cushing's disease, Guillain-Barré syndrome, myotonic dystrophy, urinary incontinence, hyperthyroidism, pituitary function disorders, hypertension or hypotension.

    摘要翻译: 公开了具有本文所定义的通式(I)的化合物,其制备方法及其用于预防或治疗涉及食欲肽2受体相关功能障碍的任何疾病,例如肥胖,食欲或味觉障碍,包括恶病质, 厌食和贪食症,糖尿病,代谢综合征,呕吐和恶心,抑郁和焦虑,瘾,情绪和行为障碍,精神分裂症,睡眠障碍,不宁腿综合征,记忆学习障碍,性和心理性功能障碍,疼痛,内脏或神经性疼痛,痛觉过敏 ,异常性疼痛,消化系统疾病,肠易激综合征,神经元脱色,缺血性或出血性发作,库欣氏病,吉兰巴利综合征,强直性营养不良,尿失禁,甲状腺功能亢进,垂体功能障碍,高血压或低血压。